文献速递产科母胎医学

11例剖宫产术后子宫瘢痕妊娠期待治疗的临床分析

[Expectant management of 11 cases of cesarean scar pregnancy].
PubMed 文献 · Zhonghua Fu Chan Ke Za Zhi · 2017-01-01

回顾性分析2015年1月至2017年3月广州医科大学附属第三医院11例孕早期诊断的剖宫产术后子宫瘢痕妊娠(CSP)期待治疗孕妇,9例期待至孕晚期,2例孕中期因子宫破裂终止。孕中期组流产次数多于孕晚期组(4.0±2.8 vs 1.3±1.1次,P<0.05),11例术后病理均诊断胎盘植入,6例行子宫次全切除术(6/11),无孕产妇死亡。

要点

  • CSPⅠ型或Ⅱ型、强烈要求继续妊娠者,在充分知情风险后可于三级医疗机构严密监测下继续妊娠。
  • 孕中期组流产次数4.0±2.8次,孕晚期组1.3±1.1次,两组比较差异有统计学意义(P<0.05)。
  • 11例术后病理均诊断胎盘植入,6例行子宫次全切除术(6/11),无孕产妇死亡。

核心结论

  • 对于诊断为CSPⅠ型或Ⅱ型、强烈要求继续妊娠的孕妇,在充分知情产前或产后出血、子宫破裂、子宫切除等风险后,可于三级医疗机构严密监测下继续妊娠。
  • CSP期待治疗至孕晚期的方案仍需深入研究。

研究设计与样本

  • 收集2015年1月至2017年3月于广州医科大学附属第三医院就诊的11例孕早期诊断为CSP的孕妇,均接受期待治疗。
  • 9例期待治疗至孕晚期(孕晚期组),2例期待治疗至孕中期终止妊娠(孕中期组)。

主要发现

  • 孕晚期组9例均期待治疗成功,于孕33周(+2)至36周(+5)终止妊娠;孕中期组2例均因子宫破裂终止妊娠(分别为孕17周(+2)、孕17周(+3))。
  • 孕晚期组与孕中期组孕妇的孕次、产次及既往剖宫产术次数分别比较,差异均无统计学意义(P均>0.05)。
  • 孕晚期组流产次数为(1.3±1.1)次,孕中期组为(4.0±2.8)次,两组比较差异有统计学意义(P<0.05)。
  • 孕晚期组9例中7例为CSPⅠ型、2例为CSPⅡ型;孕中期组2例均为CSPⅢ型。
  • 11例术后病理诊断均为胎盘植入;无孕产妇死亡;6例行子宫次全切除术(6/11);11例产后出血量为(3 582±510)ml;9例新生儿存活。

关键数值与推荐

  • 孕晚期组与孕中期组孕次、产次及既往剖宫产术次数比较,P均>0.05。
  • 孕晚期组流产次数(1.3±1.1)次 vs 孕中期组(4.0±2.8)次,P<0.05。
  • 11例产后出血量为(3 582±510)ml。
  • 6例行子宫次全切除术(6/11)。

临床怎么用

  • 作者认为,对于诊断为CSPⅠ型或Ⅱ型、强烈要求继续妊娠的孕妇,在充分知情产前或产后出血、子宫破裂、子宫切除等风险后,可于三级医疗机构严密监测下继续妊娠。
  • 作者认为,CSP期待治疗至孕晚期的方案仍需深入研究。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To explore the natural courses of 11 patients with cesarean scar pregnancy (CSP) with expectant management. Methods: Eleven patients with CSP who were diagnosed in the first trimester in the Third Affiliated Hospital of Guangzhou Medical University from January 2015 to March 2017 were recruited. All of them received expectant management. Nine pregnancies continued to the third trimester (the third trimester group), and 2 patients were expected to the second trimester (the second trimester group). The gestational age at diagnosis, CSP type, gravidity, parity, miscarriage and previous cesarean section history, gestational weeks at termination, amount of postpartum hemorrhage, prenatal and postnatal hemoglobin levels, pregnancy outcomes and obstetric complications were compared between the two groups. Results: The third trimester group terminated pregnancies between 33(+2) and 36(+5) weeks. The second trimester group terminated in the second trimester because of rupture of uterus (at 17(+2), 17(+3) weeks). There was no statistical difference between the two groups regarding the number of gravidity, parity and previous cesarean section (all P>0.05) . The number of miscarriage in the second trimester group was 4.0±2.8, and in the third trimester group was 1.3±1.1 (P<0.05) . In the third trimester group, 7 cases were CSP typeⅠand 2 cases were CSPⅡ. In the second trimester group, 2 cases were both CSP type Ⅲ. Eleven cases were diagnosed placenta accreta pathologically. There was no maternal death, and 6 cases received hysterectomy (6/11). The amount of postpartum hemorrhage increased remarkably and all neonates survived (pregnancy terminated between 33(+2) and 36(+5) weeks). Conclusion: s For those diagnosed as CSP typeⅠandⅡwho urge to continue pregnancies, it's plausible to have expectant management with fully consent of obstetric hemorrhage, rupture of uterus and hysterectomy and close monitoring in tertiary hospital. The detailed expectant management of CSP is needed further exploration. 目的: 探讨剖宫产术后子宫瘢痕妊娠(CSP)期待治疗的条件及危险因素。 方法: 收集2015年1月至2017年3月于广州医科大学附属第三医院就诊的11例孕早期诊断为CSP的孕妇,其中9例期待治疗至孕晚期(孕晚期组),2例期待治疗至孕中期终止妊娠(孕中期组)。比较两组孕妇的诊断孕周、CSP分型、孕次、产次、流产次数、既往剖宫产术次数、终止妊娠的孕周、产后出血量、产前及产后血红蛋白水平、妊娠结局和产科并发症等。 结果: 孕晚期组9例孕妇,期待治疗均成功,于孕33周(+2)~36周(+5)终止妊娠;孕中期组2例孕妇,均因子宫破裂终止妊娠(分别为孕17周(+2)、17周(+3))。孕晚期组与孕中期组孕妇的孕次、产次及既往剖宫产术次数分别比较,差异均无统计学意义(P均>0.05);两组孕妇流产次数[分别为(1.3±1.1)、(4.0±2.8)次]比较,差异有统计学意义(P<0.05)。孕晚期组9例孕妇中,7例为CSPⅠ型,2例为CSPⅡ型;孕中期组2例孕妇均为CSPⅢ型。11例孕妇,术后病理诊断均为胎盘植入;无孕产妇死亡;6例行子宫次全切除术(6/11);11例孕妇产后出血量为(3 582±510)ml。9例新生儿存活。 结论: 对于诊断为CSPⅠ型或Ⅱ型、强烈要求继续妊娠的孕妇,在充分知情产前或产后出血、子宫破裂、子宫切除等风险后,可于三级医疗机构严密监测下继续妊娠;CSP期待治疗至孕晚期的方案仍需深入研究。.

来源:Zhonghua Fu Chan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. He F, Li JQ, Tang XL, et al. [Expectant management of 11 cases of cesarean scar pregnancy]. Zhonghua Fu Chan Ke Za Zhi. 2017. PMID: 28954447. doi:10.3760/cma.j.issn.0529-567X.2017.09.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。